Fyodor has commercialized the Urine Malaria Test (UMT), a non-blood dipstick test – as simple as a pregnancy test – that tells within 25 minutes if a fever is caused by malaria, making it possible for anyone with a fever to be promptly tested, particularly in settings where access to formal healthcare facilities may be limited. This project will scale the UMT and expand access to malaria testing in key emerging markets, saving lives.
